{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:37:15Z","timestamp":1759639035830,"version":"3.37.3"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022012","name":"CSIR - Institute of Microbial Technology","doi-asserted-by":"publisher","award":["OLP - 151"],"award-info":[{"award-number":["OLP - 151"]}],"id":[{"id":"10.13039\/501100022012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"crossref","award":["MLP-39"],"award-info":[{"award-number":["MLP-39"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"crossref","award":["CRG\/2018\/000297\/SERB-GAP\/0185"],"award-info":[{"award-number":["CRG\/2018\/000297\/SERB-GAP\/0185"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Cholera is a dreadful disease. The scourge of this deadly disease is still evident in the developing world. Though several therapeutic strategies are in practice to combat and contain the disease, there is still a need for new drugs to control the disease safely and effectively. Keeping in view the concern, we first successfully established an inducible yeast model to express cholera toxin subunit A, and then used this yeast model, to screen a small molecule library against cholera toxin A subunit. Our effort resulted in the discovery of a small molecule, apomorphine (a Parkinson\u2019s disease drug) effective in reducing the lethality of toxic subunit in yeast model. In addition, novobiocin, an inhibitor of ADP ribosylation process, a key biochemical event through which cholera toxin exerts its action on host, was also found to rescue yeast cells from cholera toxin A subunit mediated toxicity. Finally, the effects of both molecules were tested on the cholera toxin-treated human gut epithelial cell line HT29, and it was observed that both apomorphine and novobiocin prevented cholera toxin-mediated cellular toxicity on HT29 intestinal epithelial cells.<\/jats:p>","DOI":"10.1371\/journal.pone.0315052","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T19:16:24Z","timestamp":1733426184000},"page":"e0315052","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Administration of novobiocin and apomorphine mitigates cholera toxin mediated cellular toxicity: Lessons from cholera toxin yeast model system"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1366-196X","authenticated-orcid":true,"given":"Sonali Eknath","family":"Bhalerao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0870-9754","authenticated-orcid":true,"given":"Himanshu","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9051-5467","authenticated-orcid":true,"given":"Saumya","family":"Raychaudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"issue":"6","key":"pone.0315052.ref001","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1016\/S2214-109X(18)30230-4","article-title":"Cholera epidemic in Yemen, 2016\u201318: an analysis of surveillance data.","volume":"6","author":"A Camacho","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"1","key":"pone.0315052.ref002","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s41182-021-00376-2","article-title":"Threats and outbreaks of cholera in Africa amidst COVID-19 pandemic: a double burden on Africa\u2019s health systems","volume":"49","author":"O Uwishema","year":"2021","journal-title":"Trop Med Health"},{"issue":"4","key":"pone.0315052.ref003","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3201\/eid0904.020317","article-title":"Class I integrons and SXT elements in El Tor strains isolated before and after 1992 Vibrio cholerae O139 outbreak, Calcutta, India.","volume":"9","author":"Chowdhury SR Amita","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"pone.0315052.ref004","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fmicb.2014.00044","article-title":"Development of pVCR94\u0394X from Vibrio cholerae, a prototype for studying multidrug resistant IncA\/C conjugative plasmids.","volume":"5","author":"N Carraro","year":"2014","journal-title":"Front Microbiol."},{"issue":"8684","key":"pone.0315052.ref005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up","volume":"335","author":"JD Clemens","year":"1990","journal-title":"Lancet"},{"issue":"5748","key":"pone.0315052.ref006","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1116739","article-title":"Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization","volume":"310","author":"DT Hung","year":"2005","journal-title":"Science"},{"issue":"12","key":"pone.0315052.ref007","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1128\/AAC.01029-15","article-title":"Conjugated Linoleic Acid Reduces Cholera Toxin Production In Vitro and In Vivo by Inhibiting Vibrio cholerae toxt Activity","volume":"59","author":"JH Withey","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"pone.0315052.ref008","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1128\/JB.02409-14","article-title":"Mechanism for inhibition of Vibrio cholerae ToxT activity by the unsaturated fatty acid components of bile","volume":"197","author":"SC Plecha","year":"2015","journal-title":"J Bacteriol"},{"issue":"6","key":"pone.0315052.ref009","doi-asserted-by":"crossref","first-page":"e1002767","DOI":"10.1371\/journal.ppat.1002767","article-title":"Broad spectrum pro-quorum-sensing molecules as inhibitors of virulence in vibrios.","volume":"8","author":"WL Ng","year":"2012","journal-title":"PLoS Pathog"},{"issue":"Pt 6","key":"pone.0315052.ref010","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1099\/mic.0.077297-0","article-title":"Cyclo(valine-valine) inhibits Vibrio cholerae virulence gene expression.","volume":"160","author":"A Vikram","year":"2014","journal-title":"Microbiology (Reading)."},{"key":"pone.0315052.ref011","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fcimb.2017.00441","article-title":"Modulating the Global Response Regulator, LuxO of V. cholerae Quorum Sensing System Using a Pyrazine Dicarboxylic Acid Derivative (PDCApy): An Antivirulence Approach.","volume":"7","author":"M Hema","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"pone.0315052.ref012","first-page":"156","article-title":"Selective and Efficient Elimination of Vibrio cholerae with a Chemical Modulator that Targets Glucose Metabolism","volume":"6","author":"YT Oh","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"pone.0315052.ref013","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1099\/0022-1317-50-2-161","article-title":"Antagonism against Vibrio cholerae by diffusible substances produced by bacterial components of the human faecal microbiota","volume":"50","author":"SH Silva","year":"2001","journal-title":"J Med Microbiol"},{"issue":"7527","key":"pone.0315052.ref014","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nature13738","article-title":"Members of the human gut microbiota involved in recovery from Vibrio cholerae infection","volume":"515","author":"A Hsiao","year":"2014","journal-title":"Nature"},{"issue":"5","key":"pone.0315052.ref015","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nchembio.2336","article-title":"A Vibrio cholerae autoinducer-receptor pair that controls biofilm formation","volume":"13","author":"K Papenfort","year":"2017","journal-title":"Nat Chem Biol"},{"key":"pone.0315052.ref016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13099-016-0153-x","article-title":"Cross feeding of glucose metabolism byproducts of Escherichia coli human gut isolates and probiotic strains affect survival of Vibrio cholerae","volume":"9","author":"C Sengupta","year":"2017","journal-title":"Gut Pathog"},{"issue":"12","key":"pone.0315052.ref017","first-page":"e00486","article-title":"Glucose Metabolism by Escherichia coli Inhibits Vibrio cholerae Intestinal Colonization of Zebrafish","volume":"86","author":"D Nag","year":"2018","journal-title":"Infect Immun"},{"issue":"445","key":"pone.0315052.ref018","article-title":"Probiotic strains detect and suppress cholera in mice.","volume":"10","author":"N Mao","year":"2018","journal-title":"Sci Transl Med."},{"issue":"1","key":"pone.0315052.ref019","first-page":"132","article-title":"Commensal-derived metabolites govern Vibrio cholerae pathogenesis in host intestine.","volume":"7","author":"JS You","year":"2019","journal-title":"MicrobiomeSep 14"},{"issue":"7","key":"pone.0315052.ref020","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.cell.2020.05.036","article-title":"Interpersonal Gut Microbiome Variation Drives Susceptibility and Resistance to Cholera Infection","volume":"181","author":"S Alavi","year":"2020","journal-title":"Cell"},{"issue":"7","key":"pone.0315052.ref021","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1073\/pnas.0611643104","article-title":"Virstatin inhibits dimerization of the transcriptional activator ToxT","volume":"104","author":"EA Shakhnovich","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"pone.0315052.ref022","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1128\/IAI.00218-10","article-title":"Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host.","volume":"78","author":"K Gronbach","year":"2010","journal-title":"Infect Immun"},{"issue":"11","key":"pone.0315052.ref023","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/s41591-019-0626-9","article-title":"Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients","volume":"25","author":"I Yelin","year":"2019","journal-title":"Nat Med"},{"issue":"3","key":"pone.0315052.ref024","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/microorganisms12030492","article-title":"L-Ascorbic Acid Restricts Vibrio cholerae Survival in Various Growth Conditions.","volume":"12","author":"H Sen","year":"2024","journal-title":"Microorganisms"},{"issue":"4","key":"pone.0315052.ref025","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/EC.3.4.827-834.2004","article-title":"Modeling the function of bacterial virulence factors in Saccharomyces cerevisiae","volume":"3","author":"RH Valdivia","year":"2004","journal-title":"Eukaryot Cell"},{"issue":"1","key":"pone.0315052.ref026","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.chom.2008.06.004","article-title":"The Yeast Saccharomyces cerevisiae: a versatile model system for the identification and characterization of bacterial virulence proteins.","volume":"4","author":"KA Siggers","year":"2008","journal-title":"Cell Host Microbe"},{"issue":"1","key":"pone.0315052.ref027","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mib.2008.11.004","article-title":"Yeast as a tool to study bacterial effectors","volume":"12","author":"J Curak","year":"2009","journal-title":"Curr Opin Microbiol"},{"issue":"2","key":"pone.0315052.ref028","doi-asserted-by":"crossref","first-page":"e1005360","DOI":"10.1371\/journal.ppat.1005360","article-title":"Yeast as a Heterologous Model System to Uncover Type III Effector Function.","volume":"12","author":"C Popa","year":"2016","journal-title":"PLoS Pathog"},{"issue":"Pt 1","key":"pone.0315052.ref029","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1099\/jmm.0.012336-0","article-title":"VopF, a type III effector protein from a non-O1, non-O139 Vibrio cholerae strain, demonstrates toxicity in a Saccharomyces cerevisiae model","volume":"59","author":"R Tripathi","year":"2010","journal-title":"J Med Microbiol"},{"issue":"1","key":"pone.0315052.ref030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.gene.2013.04.071","article-title":"Alanine-scanning mutagenesis of WH2 domains of VopF reveals residues important for conferring lethality in a Saccharomyces cerevisiae model","volume":"525","author":"R Tripathi","year":"2013","journal-title":"Gene"},{"issue":"10","key":"pone.0315052.ref031","doi-asserted-by":"crossref","first-page":"e0141038","DOI":"10.1371\/journal.pone.0141038","article-title":"Identification of Critical Amino Acids Conferring Lethality in VopK, a Type III Effector Protein of Vibrio cholerae: Lessons from Yeast Model System.","volume":"10","author":"LK Bankapalli","year":"2015","journal-title":"PLoS One."},{"key":"pone.0315052.ref032","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fcimb.2017.00082","article-title":"VopE, a Vibrio cholerae Type III Effector, Attenuates the Activation of CWI-MAPK Pathway in Yeast Model System.","volume":"7","author":"LK Bankapalli","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"pone.0315052.ref033","doi-asserted-by":"crossref","first-page":"e1000005","DOI":"10.1371\/journal.pgen.1000005","article-title":"Identification of small molecule inhibitors of Pseudomonas aeruginosa exoenzyme S using a yeast phenotypic screen","volume":"4","author":"A Arnoldo","year":"2008","journal-title":"PLoS Genet"},{"issue":"2","key":"pone.0315052.ref034","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41419-017-0154-9","article-title":"Discovery of a small-molecule protein kinase C\u03b4-selective activator with promising application in colon cancer therapy","volume":"9","author":"C Bessa","year":"2018","journal-title":"Cell Death Dis"},{"issue":"10","key":"pone.0315052.ref035","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1128\/iai.62.10.4176-4185.1994","article-title":"Importance of ADP-ribosylation in the morphological changes of PC12 cells induced by cholera toxin","volume":"62","author":"C Glineur","year":"1994","journal-title":"Infect Immun"},{"issue":"1","key":"pone.0315052.ref036","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.ppat.0040009","article-title":"A functional genomic yeast screen to identify pathogenic bacterial proteins","volume":"4","author":"NL Slagowski","year":"2008","journal-title":"PLoS Pathog"},{"issue":"9","key":"pone.0315052.ref037","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s40263-019-00661-z","article-title":"Apomorphine for Parkinson\u2019s Disease: Efficacy and Safety of Current and New Formulations.","volume":"33","author":"F Carbone","year":"2019","journal-title":"CNS Drugs."},{"issue":"5737","key":"pone.0315052.ref038","first-page":"1093","article-title":"Structural basis for the activation of cholera toxin by human ARF6-","volume":"309","author":"CJ O\u2019Neal","year":"2005","journal-title":"GTP. Science"},{"issue":"9","key":"pone.0315052.ref039","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1128\/iai.59.9.2870-2879.1991","article-title":"Effect of site-directed mutagenic alterations on ADP-ribosyltransferase activity of the A subunit of Escherichia coli heat-labile enterotoxin","volume":"59","author":"Y Lobet","year":"1991","journal-title":"Infect Immun"},{"issue":"11","key":"pone.0315052.ref040","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/jcc.540161106","article-title":"Application of the multimolecule and multiconformational RESP methodology to biopolymers: Charge derivation for DNA, RNA, and proteins","volume":"16","author":"P Cieplak","year":"1995","journal-title":"Journal of Computational Chemistry"},{"issue":"7","key":"pone.0315052.ref041","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/S0021-9258(17)40578-3","article-title":"Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor","volume":"252","author":"J Moss","year":"1977","journal-title":"J Biol Chem"},{"issue":"7","key":"pone.0315052.ref042","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1073\/pnas.75.7.3050","article-title":"ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase","volume":"75","author":"DM Gill","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"pone.0315052.ref043","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1021\/bi00394a009","article-title":"ADP-ribosylation by cholera toxin: functional analysis of a cellular system that stimulates the enzymic activity of cholera toxin fragment A1","volume":"26","author":"DM Gill","year":"1987","journal-title":"Biochemistry"},{"issue":"1\u20132","key":"pone.0315052.ref044","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11010-007-9667-3","article-title":"Mono ADP-ribosylation inhibitors prevent inflammatory cytokine release in alveolar epithelial cells","volume":"310","author":"M Del Vecchio","year":"2008","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"pone.0315052.ref045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0167-7012(91)90020-Q","article-title":"A bioassay for cholera-like toxins using HT29 cells","volume":"14","author":"Z Charania","year":"1991","journal-title":"Journal of microbiological methods"},{"issue":"2","key":"pone.0315052.ref046","first-page":"170","article-title":"Effects of enteropathogenic bacteria & lactobacilli on chemokine secretion & Toll like receptor gene expression in two human colonic epithelial cell lines","volume":"130","author":"NS Nandakumar","year":"2009","journal-title":"Indian Journal of Medical Research"},{"issue":"2","key":"pone.0315052.ref047","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.antiviral.2010.08.015","article-title":"Cholera toxin inhibits HIV-1 replication in human colorectal epithelial HT-29 cells through adenylate cyclase activation","volume":"88","author":"S Gauthier","year":"2010","journal-title":"Antiviral research"},{"issue":"8","key":"pone.0315052.ref048","first-page":"380","volume":"1","author":"MR Edwards","year":"2015","journal-title":"High-Throughput Minigenome System for Identifying Small-Molecule Inhibitors of Ebola Virus Replication. ACS Infect Dis. 2015 Aug 14"},{"issue":"22","key":"pone.0315052.ref049","doi-asserted-by":"crossref","first-page":"8901","DOI":"10.1021\/jo801312r","article-title":"The design, synthesis, and evaluation of coumarin ring derivatives of the novobiocin scaffold that exhibit antiproliferative activity","volume":"73","author":"AC Donnelly","year":"2008","journal-title":"J Org Chem"},{"issue":"3\u20134","key":"pone.0315052.ref050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/10409239109114072","article-title":"DNA gyrase: structure and function","volume":"26","author":"RJ Reece","year":"1991","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"9","key":"pone.0315052.ref051","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2174\/1389557516666161223155525","article-title":"Novobiocin Analogs as Potential Anticancer Agents.","volume":"17","author":"A Dlugosz","year":"2017","journal-title":"Mini Rev Med Chem."},{"issue":"2","key":"pone.0315052.ref052","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.22319","article-title":"Apomorphine treatment in Alzheimer mice promoting amyloid-\u03b2 degradation","volume":"69","author":"E Himeno","year":"2011","journal-title":"Ann Neurol"},{"key":"pone.0315052.ref053","article-title":"Apomorphine: A Novel Efficacy for Alzheimer\u2019s Disease and Its Mechanisms","volume":"2","author":"Y. Ohyagi","year":"2012","journal-title":"Journal of Alzheimers Disease & Parkinsonism 2012"},{"issue":"1","key":"pone.0315052.ref054","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0006-291X(85)91864-9","article-title":"Dopamine receptors on photoreceptor membranes couple to a GTP-binding protein which is sensitive to both pertussis and cholera toxin","volume":"133","author":"MR Brann","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"pone.0315052.ref055","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/mds.28686","article-title":"The Emerging Role of Phosphodiesterases in Movement Disorders","volume":"36","author":"R Erro","year":"2021","journal-title":"Mov Disord"},{"issue":"08","key":"pone.0315052.ref056","doi-asserted-by":"crossref","first-page":"950","DOI":"10.4236\/aim.2018.812064","article-title":"Lessons from Vibrio Pathogen and the Comparative Study of Vaccines Developed.","author":"T. Rahman","year":"2018","journal-title":"Adv Microbiol"},{"issue":"364","key":"pone.0315052.ref057","first-page":"cm6","article-title":"Pheromone signaling pathways in yeast","author":"HG Dohlman","year":"2006","journal-title":"Sci STKE"},{"issue":"1","key":"pone.0315052.ref058","doi-asserted-by":"crossref","first-page":"e0119121","DOI":"10.1128\/msystems.01191-21","article-title":"Parkinson\u2019s Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats.","volume":"7","author":"SP van Kessel","year":"2022","journal-title":"mSystems"},{"key":"pone.0315052.ref059","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s002489900020","article-title":"Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine","volume":"33","author":"EA Smith","year":"1997","journal-title":"Microbial ecology"},{"issue":"5","key":"pone.0315052.ref060","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1079\/BJN20041101","article-title":"Effects of esculin and esculetin on the survival of Escherichia coli O157 in human faecal slurries, continuous-flow simulations of the rumen and colon and in calves","volume":"91","author":"SH Duncan","year":"2004","journal-title":"British journal of nutrition"},{"key":"pone.0315052.ref061","doi-asserted-by":"crossref","first-page":"1452784","DOI":"10.3389\/fnut.2024.1452784","article-title":"Modulation of gut microbiome in response to the combination of Escherichia coli Nissle 1917 and sugars: a pilot study using host-free system reflecting impact on interpersonal microbiome.","volume":"11","author":"K Heer","year":"2024","journal-title":"Frontiers in Nutrition"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0315052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T19:16:50Z","timestamp":1733426210000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0315052"}},"subtitle":[],"editor":[{"given":"Rui","family":"Tada","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":61,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0315052","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2024,12,5]]}}}